An Australian government research fund has granted $1.7 million (US$1.1 million) to target three major cardiovascular diseases using messenger RNA (mRNA) technology, accelerating the use of gene therapy’s treatment of diseases beyond COVID-19.
Baker Heart and Diabetes Institute, one of Australia’s oldest medical research organisations focused on heart disease, welcomed the grant from Medical Research Future Fund (MRFF).
